Background Data on work-related ill-health (WRIH) in the Republic of Ireland is inconsistent.
Introduction
Collection of data on work-related ill-health (WRIH) in the Republic of Ireland (ROI) is inconsistent, with no mandatory requirement for employers to report occupational diseases and/or illness apart from diseases liable for compensation contained in the International Labour Organisation's list of prescribed diseases and returns to EUROSTAT [1] [2] [3] . Under occupational health and safety legislation ROI employers are obliged to notify the Health and Safety Authority (HSA) of accidents that cause injury resulting in absence from work. However, much like its UK counterpart (RIDDOR), the ROI system suffers from unreliable data and under-reporting [4, 5] . In addition, there are a number of state and private organizations that collect some occupational health data, including the Central Statistics Office (CSO, via the 'Accidents and Illness' module in the quarterly Household National Survey) [6, 7] , the Department of Social Protection, via injury benefit schemes, the State Claims Agency (compensation for injuries), and private insurance companies which provide income protection policies and personal injury cover [4] . The HSA recognized the deficit of available data and reporting methods for WRIH in ROI [5] and has sought to address this deficit by establishing a number of surveillance schemes [5] . The schemes, collectively known as THOR-ROI, are based on The Health and Occupation Research (THOR) network which is a UK-wide series of surveillance schemes (based at The University of Manchester) enabling physicians, clinical systems specialists, occupational physicians (OPs) and general practitioners (GPs) to report cases of WRIH seen during their clinical practice [8] . EPIDERM-ROI and SWORD-ROI were implemented in 2005, enabling ROI dermatologists and chest physicians to report cases of work-related skin and respiratory disease, respectively [9] , while in 2007, OPRA-ROI was established, enabling OPs to report any case of WRIH.
The aim of this study was to provide an overview of incident cases of WRIH reported to THOR-ROI and to compare these with cases reported (to the corresponding UK schemes) in Northern Ireland (NI) and Great Britain (GB) over the same period.
Methods
The methodology behind THOR has been described in detail previously [10] [11] [12] . Briefly, participants are asked to report new cases of disease seen during their reporting month that they believe to have been caused or aggravated by work. The decision as to whether the case is work-related is left to the physician, although general guidance on reporting is provided [8] . The methodology was established using a paper-based report card but, since 2002, reporters have been encouraged to provide data in an electronic format. The most recent THOR schemes, including all those based in the ROI, were designed to use electronic reporting methods exclusively. For each case, reporters are asked to provide information on diagnosis, age, gender, geographical location, job title, industry, suspected agent and date of onset of symptoms; systems used to code data are described in full elsewhere [13] [14] [15] . Physicians may participate every month ('core' reporters) or for one randomly allocated reporting month per year ('sample' reporters). GB and NI schemes comprise a mix of 'sample' and 'core' reporters, whereas ROI physicians report exclusively as 'core'. Estimated cases for UK and NI are calculated by multiplying the cases reported by sample reporters by 12 and adding them to the cases reported by core reporters [16] . 'Active' reporters are those who returned a web form at least once during the study period either containing cases or declaring 'I have nothing to report this month'.
Data on cases of WRIH reported to EPIDERM, SWORD and OPRA by physicians in GB, NI and ROI from 2005 to 2012 were extracted from the databases and compared by diagnosis, age and gender, industry and occupation and suspected agent.
Annual average incidence rates (per 100 000 employed) of dermatologist and chest physician reported WRIH were estimated based on previously published methodology [17] . Incidence rates based on OP data were not calculated because it was not possible to determine accurately the population covered by OPs in all three geographical areas (access to an OP in the UK and the ROI is biased towards the public sector and larger employers). Two different rates are presented, 'adjusted' and 'unadjusted'. In the former, the numerator is adjusted for participation (the proportion of the total dermatologists or chest physicians (in the ROI or NI or GB) participating in THOR) and response (the proportion of participating physicians actively responding each month). The denominator was the total number of persons employed (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) obtained from the UK Labour Force Survey (LFS) [18] or the ROI National Household Survey [19] . Incidence rates were calculated for ROI and GB and for total work-related skin disease, contact dermatitis (CD) and total workrelated respiratory disease only (the number of actual case reports in NI and in other diagnostic sub-groups were deemed too low accurately to determine meaningful incidence rates).
Data 
Results
Active participation was generally higher amongst physicians reporting in GB and NI than in ROI (Table 1) . Physicians in the ROI reported more actual cases per active reporter per year than physicians in GB or NI. Adjusting for differences in the ratio of core:sample physicians between the three areas, the number of estimated cases per active reporter per year was similar for the ROI and GB and higher (except for chest physicians) for NI. ROI physicians reported a total of 1431 actual case reports of WRIH compared with 423 actual (3932 estimated) case reports in NI and 17 696 actual (63 874 estimated) case reports in GB (Table 2 ).
An overview of case reports by diagnostic category reported by OPs to OPRA during the period 2007-2012 is provided in Table 2 . Diagnoses were predominantly mental ill-health (ROI 51%, NI 61% and GB 56%), and musculoskeletal disorders (ROI 36%, NI and GB 31%), with fewer skin, respiratory and 'other' WRIH diagnoses (e.g. hearing loss and infectious disease). OPs in the ROI and GB reported proportionally more cases in females (ROI 70%, GB 54%) compared to NI (46%) and the mean age of (all) cases reported was 43 (ROI) and 44 (NI and GB). Case reports in the ROI were predominantly from the health and social work sector (83%) while for NI and GB the majority of the cases of WRIH were reported from three sectors: health and social work, public administration and defence and manufacturing (NI 90%, GB 70%) ( Table 3 ).
The major diagnostic categories reported by dermatologists are provided in Table 2 . Estimated diagnoses were predominantly CD (ROI 95%, NI 59%, GB 71%) with NI and GB case mix also including a substantial proportion of neoplasia diagnoses (NI 41%, GB 23%). ROI dermatologists diagnosed allergic CD proportionally more than irritant CD (allergic 53%, irritant 38%) compared to NI and GB dermatologists (NI allergic 28%, irritant 40%; GB allergic 39%, irritant 42%). CD cases were reported more frequently in females (ROI 54%, NI 61%, GB 58%) and the mean age (all cases) of CD was similar for all three areas; ROI 37, NI 33 and GB 38.
Diagnoses of work-related skin disease by major industrial division are shown in Table 3 . Restricting the comparison to CD, diagnoses in the ROI, NI and GB were most frequently reported in the health and social care sector and other service activities sector (which includes hairdressing and other beauty treatments).
The annual average incidence rate for dermatologistreported skin disease in the ROI was 2 per 100 000 employed (95% confidence intervals [CI] 1.9-2.8). After adjusting for 'non-participation' and 'non-response' this increased to an estimate of 32 per 100 000 employed (95% CI 28.4-35.6). The 'unadjusted' and 'adjusted' incidence rates for GB were 7 (95% CI 4.8-9.4) and 14 (95% CI 8.1-20.2) per 100 000 employed (Table 4) .
Chest physicians in the ROI reported proportionally more asthma (ROI 42%, GB 9%, NI 11%) and less non-malignant pleural disease (GB 43%, NI 35%, ROI 20%) and mesothelioma (GB 27%, NI 19%, ROI 5%) ( Table 2) . Respiratory cases were reported most frequently in males (ROI 82%, NI 100%, GB 90%) and the mean age of (all) cases in the ROI was 54 compared to 64 (GB) and 69 (NI). For all three geographical areas, construction and manufacturing were the two industrial sectors for which diagnoses were most frequently reported (Table 3) .
The annual average incidence rate for chest physicianreported respiratory disease in the ROI was estimated at 1 (95% CI 0.3-1) per 100 000 employed, increasing to 32 (95% CI 28.4-35.6) after adjusting for 'non-participation' and 'non-response'. This compared to incidence rates of 8 (95% CI 6.1-10.7) and 15 (95% CI 11.3-19.6) per 100 000 employed for chest physician reported respiratory disease in GB (Table 4) .
Discussion
This study confirms the ability to measure reported incidence of WRIH in the ROI as in the UK via the THOR surveillance schemes. It also suggests that the findings are broadly consistent with the pattern of employment and exposure in each country; for example, fewer asbestosrelated diseases were reported in the ROI. Health and Safety Authority data ranks Ireland 13th out of 20 countries for incidence of mesothelioma in a study carried out in 2003 [21] . While studies of asbestos use in ROI are few there appears to be some evidence to suggest that the scale of asbestos use in ROI was much less than in the UK [22] .
ROI physicians overwhelmingly reported CD diagnoses for work-related skin disease. No cases of neoplasia were reported in the ROI, in spite of existing data that show that non-melanoma skin cancer accounts for the largest proportion of new cancer cases in the ROI annually, with between 2% and 8% of these attributable to a person's occupation [5] . Similarly, a larger proportion of asthma diagnoses were reported in the ROI than GB or NI. Existing data has shown that worldwide the ROI has the fourth highest incidence of asthma [23] . The recruitment campaign in the ROI (in particular for EPIDERM), was focused on recruiting dermatologists carrying out patch testing with less emphasis on occupational malignancy. Scheme information available on the HSA website refers to the THOR-ROI schemes as 'online reporting systems for occupational asthma and occupational dermatitis', so this emphasis may well account for the larger proportion of asthma and CD cases reported to EPIDERM-ROI and SWORD-ROI [5] .
Mental ill-health and musculoskeletal disorders were reported more frequently than either dermatological or respiratory diagnoses by OPs in the three geographical areas. This observation matches data from the Quarterly National Household Survey [19] which found that illnesses reported by those in employment (self-reports) in 2004 were mainly musculoskeletal (50%) and mental ill-health conditions (20%). This case mix pattern of predominantly musculoskeletal and mental ill-health reporting is observed in the UK data also [24] . Two different rates are presented: 'adjusted' and 'unadjusted'. In the former, the numerator is adjusted for participation (the proportion of the total dermatologists or chest physicians in the ROI, NI or GB participating in THOR) and response (the proportion of participating physicians actively responding each month) [17] . However, this makes the assumption that non-participating or non-responding physicians would behave in the same way as participating or responding physicians, which may not be accurate. In addition adjusting for non-response assumes that non-responders had cases to report but didn't, rather than the absence of reportable cases during their reporting month. In this latter case, reporters are encouraged to respond with 'I have no cases to report'. As such the two rates provided in Table 4 ('unadjusted' and 'adjusted') may be considered as the possible upper and lower bounds of estimated incident cases of WRIH. Contact dermatitis  80  9  18  161  5  313  1699  6  Other skin disease  10  0  0  63  422  Respiratory  Asthma  6  2  1  12  1  65  318  3  Rhinitis  1  1  12  26  136  Inhalation accidents  4  1  12  16  82  Other respiratory  6  0  0  36  286  Other  Other work related ill-health  30  3  6  72  2  196  1076  4  Total diagnoses  1024  100  312  3359  100  6620  31 106  100  Total case reports  963  308  3344  6120  29 407  Annual average cases  161  51  557  1020  4901  All physicians  Total diagnoses  1488  429  3949  18 528  66 235  Total case reports  1431  423  3932  17 696  63 874 a A case may be assigned more than one diagnosis, so that sums total more (or less) than 100%. Of the physician groups reporting to THOR in the ROI (and generally in the UK), OPs reported more cases per active reporter than dermatologists and chest physicians. Although the results comparing OP reporting between the ROI and the UK presented here are of value it would also be beneficial to be able to estimate and compare incidence rates for the three areas. OP-derived incidence rates have not been calculated in this study due to unresolved issues in determining the workforce covered by OPs. While work has been undertaken to determine the workforce covered by OPs in GB, this has not yet been achieved for the ROI (or NI) [25] . It is anticipated that future work will address this.
As of January 2013, 47 physicians were participating in THOR's schemes in the ROI. Clearly there are other eligible specialists who do not currently report to THOR for a variety of reasons (have declined to participate, haven't been recruited or participate but fail to return any reports). Efforts are constantly made to improve recruitment and increase participation in THOR-ROI but despite the continuing work of the three scheme 'champions' to disseminate and publicize the schemes in the ROI, via conference presentations, newsletters and so on, the number of active reporters to the schemes remains relatively low compared to corresponding UK schemes. Efforts to increase participation in the THOR schemes continue [26] . Moreover, publication of findings in the peer-reviewed literature, as well as the circulation of quarterly reports to the reporting physicians, are important ways of sharing the findings with them and encouraging their continuing involvement. Notably ethical approval has recently been granted to set up a GP reporting scheme (based on the UK THOR-GP scheme) [27] in the ROI. Data collected from GPs is valuable for a number of reasons: GPs see patients with all categories of WRIH and are likely to capture more cases as they are the first port of call when a patient has a health problem. The recruitment of GPs to THOR-ROI is therefore likely to increase the amount of information reported through these schemes. GPs are also able to provide information on any sickness absence associated with the illhealth and additional patient management information such as referrals to other health care providers and services. Data are currently available from nine full years of clinical specialist reporting (skin and respiratory), and seven full years of reporting by OPs in the ROI. THOR-ROI remains an important source of data on WRIH to date in ROI. As the amount of data collected by THOR-ROI increases (including from GPs) it will be possible to conduct more detailed analyses and draw stronger conclusions in comparing WRIH in the ROI and UK, including identifying trends in incidence [26] .
National occupational health surveillance data in the UK have been collected via THOR and reported upon for over two decades [10] [11] [12] . These data make an important contribution to National Statistics on UK Health and Safety [27] and it is anticipated that THOR in the ROI will provide information of comparable importance. An important offshoot of such data collection is comparison by country or by region [28] . This is the first paper to present an overview of THOR data collected by physicians in ROI compared with data collected in the UK. The investigation of comparative incidence of occupational disease or WRIH is one of the aims of the EU COST funded MODERNET network within which both the ROI and the UK are active participants [29] .
Key points
• Reports from specialist clinical physicians identify occupational asthma as the most frequently reported work-related respiratory disease in the Republic of Ireland, with proportionally less asbestos-related occupational respiratory disease reported than in the UK, and contact dermatitis as the most frequently reported work-related skin disease in Ireland, with proportionally fewer neoplasia cases reported than in the UK or Northern Ireland.
• Occupational physicians in the Republic of Ireland report musculoskeletal and mental ill-health disorders most frequently; this is also observed in the UK and Northern Ireland.
• The study highlights the viable reporting of workrelated ill-health in the Republic of Ireland and the need for consistent and dedicated surveillance schemes to continue and improve the collection of data.
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